EHI
LNTH icon

Eagle Health Investments’s Lantheus LNTH Stock Holding History

Eagle Health Investments’s Portfolio LNTH Stock Details LNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-43,200
Closed -$4.74M – 23
2024
Q3 		$4.74M Hold
43,200
– – 0.9% 19
2024
Q2 		$3.47M Hold
43,200
– – 0.61% 22
2024
Q1 		$2.69M Hold
43,200
– – 0.5% 27
2023
Q4 		$2.68M Sell
43,200
-373,500
-90% -$25.3M 0.54% 22
2023
Q3 		$29M Buy
416,700
+163,500
+65% +$12M 6.38% 6
2023
Q2 		$21.2M Sell
253,200
-31,600
-11% -$2.84M 3.97% 12
2023
Q1 		$23.5M Buy
+284,800
New +$18.4M 4.58% 12

Other funds holding LNTH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Eagle Health Investments's LNTH Position: Q4 2024 in Review

Eagle Health Investments sold out of Lantheus (LNTH) in Q4 2024, closing a stake of 43,200 shares — an estimated $4.74M sold.

Eagle Health Investments first reported a position in LNTH in Q1 2023 and held it in 7 quarters. The position peaked at $29M in Q3 2023. 487 funds tracked by Wall St. Rank hold LNTH as of Q4 2024.

  • Eagle Health Investments reported no remaining Lantheus position as of Q4 2024 after selling out during the quarter.
  • Eagle Health Investments sold 43,200 Lantheus shares in Q4 2024, an estimated $4.74M.
  • Eagle Health Investments first reported a position in Lantheus in Q1 2023 and held it in 7 quarters.
  • Eagle Health Investments's Lantheus position peaked at $29M in Q3 2023.
  • 487 funds tracked by Wall St. Rank held Lantheus as of Q4 2024.

Based on Eagle Health Investments's 13F filing for Q4 2024, filed 12 Feb 2025.